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In some countries cancer of the uterine cervix is the major
cause of death by cancer in women (Cancer Statistics, 1981).
In the European Community it is responsible for many
thousands of deaths per year and there is evidence that the
incidence of cervical intraepithelial neoplasia (CIN) is in-
creasing in the western world particularly in young women
(Wolfendale et al., 1983; Winkelstein & Selvin, 1989; Elliot et
al., 1989; Johnson & Rowlands, 1989).
The standard method for early detection of CIN is the
Papanicolaou test (PAP test) that is both subjective and
labour intensive and subject to variability in sampling techni-
que (Wolfendale, 1991). Moreover, there have been many
reports of disturbingly high percentages of false negatives
(Shield et al., 1987; Ismail et al., 1989; Mitchell et al., 1990;
Mitchell & Medley, 1991). There has been therefore con-
siderable interest over the years in examining alternative
and/or supplementary methods of detection in early lesions
of the cervix; in particular, attention has been directed at
developing quantitative biochemical assays that would be
suited to automated systems of measurement.
Early attempts which were moderately successful were to
examine vaginal fluid samples for enzyme activity, especially
the activity of glucose-6-phosphate dehydrogenase (Rees et
al., 1970). It is known that proliferating cells have a high
pentose phosphate shunt activity (Coulton, 1977). Numerous
early studies have shown that this metabolic pathway is
increased in many types of tumour (Glock & McLean, 1954;
Chayen et al., 1962). Because major functions of the non-
oxidative and oxidative sequences of the pentose phosphate
pathways are the supply of ribose-5-phosphate for incorpora-
tion into ribonucleic acid and coenzymes, and the reduction
of NADP+ to NADPH for metabolic synthetic reactions
respectively, it can be expected that the pentose phosphate
pathways play important roles in the metabolism of tumours
(Weber, 1983) and rapidly dividing cells (Wood, 1985). The
first enzyme of the pentose pathway is glucose-6-phosphate
dehydrogenase (G6PD) and the second 6-phosphogluconate
dehydrogenase (6PGD). For a comprehensive review of
G6PD see Yoshida et al. (1986) and of the pentose pathway
see Wood (1985).
Both glucose-6-phosphate dehydrogenase (G6PD) and 6-
phosphogluconate dehydrogenase (6PGD) have been shown
by histochemical studies to be increased in carcinoma of the
cervix (Cohen & Way, 1966; Widy & Kierski, 1967; Blonk,
1969; Heyden, 1974; Nilson et al., 1987). Recently a study on
a number of cell lines has supported this further by showing
that maximal activities of G6PD and 6PGD in many
tumourigenic lines were elevated as compared with normal
lines (Board et al., 1990). However, the pentose shunt is also
increased in normal dividing cells, such as the basal cells of
the epithelia, in stimulated polymorphonuclear leucocytes
and in inflammatory conditions, as compared to resting or
non-dividing, desquamating cells.
Biochemical measurements (Rees et al., 1970) of G6PD
and 6PGD in samples of vaginal fluid showed elevated
activity in samples from patients with carcinoma of the cervix
compared with samples from normal patients. However,
there were problems of variable contamination by red blood
cells, which are rich in these enzymes, inflammatory cells, and
micro-organisms.
In the present study interference due to these factors has
been avoided by a preparative step that ensures that only
cervical epithelial cells are present in the sample material. A
suitable method for this purification has been described else-
where (Slater et al., 1992). It is a relatively simple separation
method and ensures that only morphologically distinct epi-
thelial cells are examined for G6PD activity. This particular
layer of epithelial cells do not normally divide and des-
quamate upon reaching the surface layer. Thus their enzyme
activity would be expected to be low in normal healthy cases.
In this paper we report the results of both cytochemical
and biochemical methods to assess the difference in activities
of G6PD and 6PGD in purified preparations of squamous
epithelial cells from normal patients and from patients with
different grades of CIN.
Materials and methods
Samples
Cervical smears were obtained from four different sources;
two general hospitals in the UK, one health centre in the UK
and one University Clinic in Turin, Italy. All patients who
were graded as CIN in this study were diagnosed by conven-
tional cytology and subsequently confirmed by conventional
histology. The samples were obtained using a spatula for
exocervix and cytobrush for endocervix and placed into
universal vials containing phosphate-buffered saline (PBS no
Ca/Mg, Sigma Chemical Co). These samples were processed
no more than 2 h after collection, although this is not
critical.
Processing
The samples were centrifuged and separated on a discon-
tinuous Percoll gradient (Pharmacia) as described in detail
previously (Slater et al., 1992). This produced, 1, 2 or 3
bands containing squamous epithelial cells that were col-
lected and washed with PBS. A suspension of these cells was
used for cytochemical and/or biochemical assays.
We used G6PD for the biochemical measurements of
initial rates of reaction, and 6PGD for the cytochemical
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staining where, due to the 40 min incubation (see below) G6P
would also be significantly metabolised by the glycolytic
pathway. In general, G6PD and 6PGD are known to change
in concert in physiological and pathological conditions
(Wood, 1985).
Quantitative measurements of6PGD activity
Microcytospectrophotometric studies A suspension of cells
was smeared onto pre-washed slides and allowed to dry in
air. A mixture of 2 mM 6-phosphogluconate (6PG), 0.5 mM
nicotinamide adenine dinucleotide phosphate (NADP+,
sodium salt), 0.1% nitroblue tetrazolium (NBT) and 0.14 mM
phenazine methosulphate (PMS) was buffered at pH 8.5 in
0.3 M glycyl glycine buffer. All reagents were obtained from
Sigma Chemical Company unless otherwise stated. This mix-
ture was prepared immediately before addition to cells and
protected from light. The cells were exposed to this reaction
mixture on a slide for 40 min at 37°C in a 5% CO2 incubator
and protected from light. The reaction mixture was removed
and the slides carefully washed with distilled water before
dehydrating progressively through 70%, 90%, 95% and
100% ethanol, clearing in xylol and mounting in Depex
mounting medium.
In the first step of the pentose phosphate shunt reducing
equivalents are passed onto NADP+ to yield NADPH which
reduces PMS, which in turn reduces NBT, the final electron
acceptor in this cycling system. A blue formazan precipitate
is formed with a characteristic absorption maximum of
540 nm (van Noorden & Tas, 1980). For details of this
cycling reaction see Slater and Sawyer (1962) and Slater et al.
(1964). The intensity of staining is proportional to the
enzyme activity and varies in each individual cell. The absor-
bance at 540 nm was measured using computerised micro-
cytospectrophotometry (Lee et al., 1991). In brief, the
method employs comparison of the digitised image of cells
selected by the operator with a blank background field from
the same slide and calculates the individual absorbances of
the picture elements (pixels) from which the absorbances can
be obtained. The video images were obtained using a
1 Hitachi KP4 video camera mounted on a Zeiss photomicro-
scope. Illumination was via a narrowband interference filter
I = 540 ± 10 nm) (Glen Spectra Ltd) and images were obtain-
ed using a 10 x objective lens. Luminosity data were hand-
led by an Intellect 200 Image Analysing system interfaced to
a PDP 11/23 + host computer. Measurements were made
employing a version of the 'CYTABS' (copyright DJS) pro-
gramme (Mistry et al., 1991). Samples were measured 'blind',
i.e. each slide was denoted a code which was revealed after
all the measurements were completed.
Quantitative measurements ofG6PD
Biochemical studies G6PD was assayed on samples of lysed
cells. Sampling and processing of smears was carried out as
for cytochemical studies. Following harvesting of squamous
epithelium the cells were counted using a haemocytometer,
and Trypan blue exclusion to identify dead epithelial cells
and the presence of other cell types. Samples that were seen
to contain many dead cells or significant contamination by
other cells were not used for biochemical measurement. The
cells were lysed in 0.5 ml of 0.1% Nonidet P40 and vortexed.
The reaction mixture for the assay which was carried out at
25°C consisted of 0.1 M glycine buffer, pH 8.5, 3 mM G6P,
0.5 mM NADP+ and 0.06 mM dichlorophenolindophenol
(DcPIP). At the beginning of the assay 0.05 ml 10 mM PMS
was added to the test and control cuvettes. The reaction was
started by the addition of 0.5 ml of 0.1% Nonidet P40
detergent to the control cuvette and 0.5 ml of cell lysate to
the test cuvette. The initial decrease in absorbance with time
was followed spectrophotometrically at 600 nm. Due to vari-
able turbidity of the sample the cuvettes were placed as close
as possible to the light source to keep resulting stray light to
a minimum. The reaction was followed for 5 min and the
initial rate of reaction calculated in terms ofabsorbance units
x i0-5 per minute per 104 cells. A calibration standard was
run at the end of each set of samples by measuring the rate
of reaction of a standard preparation of G6PD obtained
from Sigma Chemical Co. (type XI activity 345 u mg-' pro-
tein).
Results
Cytochemical assay (6PGD)
In the presence of 6PG and coenzyme the amount of NADP
reduction is proportional to the 6PGD activity in the cell.
With NBT present as a suitable final electron acceptor the
resultant water-insoluble formazan particles precipitate in the
cytoplasm of the cell. The formazan exhibits a strong affinity
for protein (Heyden, 1979) and the reaction product is
readily visible by light microscopy (Figure 1). The staining
intensity is proportional to the activity of 6PGD in the cell.
In the absence of either 6PG or NADP no staining occurred.
Approximately 100 individual cells were measured from
each sample. In many of the normal smears the staining
intensity of the majority of cells had low absorbance values.
Examples of the data from a normal sample and one case of
CIN and are illustrated in the frequency distribution histo-
grams of the staining intensity (Figure 2). In Figure 2 no
normal cells showed staining greater than 0.04 absorbance
units. In contrast, many of the abnormal smears, i.e. CIN 1,
2 or 3 contained a proportion of cells with significantly
higher absorbance values.
In order to compare the results from normal and pre-
cancerous samples certain absorbance values were chosen to
represent 'cut off' points. The number of cells having absor-
bances higher than these values were counted for several
samples. This number was then expressed as a percentage of
the total number of cells counted in each sample. Figure 3
shows a summary of all the groups of data from normal and
abnormal smears. The data comprise samples obtained from
three different colposcopy clinics and represent the involve-
ment of several research workers. Collection and analysis of
these data covers a period of 3 years from 1987 to 1990; this
has to be borne in mind when analysing the overlap between
cytological and clinical diagnoses. In Figure 3 the 'cut-of
point chosen was 0.15 extinction units. The number of cells
with staining intensities higher than 0.15 were counted and
expressed as a percentage of the total number of cells
measured. In the normal group only 12 out of 61 cases
showed cells with staining intensities above 0.15 absorbance
units, whereas 11 out of 14 cases of CIN 1, ten out of 11
cases of CIN 2 and ten out of 15 cases of CIN 3 exhibited
staining intensities above O.D. 0.15. Although there is large
overlap between grades there are more cells with high 6PGD
activity in samples from patients with CIN 1, 2 and 3 com-
pared to normal.
Some experiments were done using G6PD instead of
6PGD for cytochemical staining and the results were very
similar in terms of differences between normal samples and
CIN (data not included).
Biochemical assay (G6PD)
The activity of G6PD was monitored by following the rate of
decrease in absorbance at 600 nm in the presence of lysed
cells. This cycling procedure is analogous to the assay em-
ploy_d for cytochemical analysis in that reducing equivalents
are passed to a final electron acceptor. Normal smears taken
from patients visiting a routine health centre showed very
low activity of G6PD using this method (Figure 4) as com-
pared to cases of CIN. There is a definite correlation between
G6PD activity and progressive stages of CIN. The total false
negatives were 1 (n = 33; 3%) for CIN and the false positives
were 3 (n = 21; 14%). For CIN 2 and CIN 3 there were no
false negatives. Overlaps between grades of CIN are still
present but there is a general trend towards higher activity
with increasing grade of CIN. The two cases of invasiveG6PD AND G6GD ACTIVITY AND CERVICAL CANCER 187
Figure 1 The presence of formazan deposits in cells from the squamous epithelium from the uterine cervix. Squamous cervix
epithelial cells obtained after gradient separation and incubated with 2mM 6-phosphogluconate, 0.5 mM NADP, 0.1% NBT and
0.14mM PMS in 0.3M glycl glycine buffer, pH 8.5 for 30 min at 37°C in the dark. Bar = 40 gm.
cancer in this study gave values of 6,000 and 10,000 OD
units x 10-5 per minute per 104 cells under the same condi-
tions, and thus would be well off-scale in Figure 4.
For one sample of CIN 3 both cytochemical staining
(6PGD) and the biochemical rate of reaction (G6PD) were
studied. The results showed that 23% of epithelial cells had a
staining intensity above 0.15 absorbance units; the equivalent
biochemical activity was 90 O.D. units x 10' per minute per
104 cells (see Figures 3 and 4). Table I summarises the false
positives and false negatives for both cytochemical and bio-
chemical methods of measurements based on a discrimina-
tory line drawn at equivalent points in Figure 3 and 4.
Discussion
The main objective of this study was to test the potential of
biochemical measurements of the activity of glucose-6-phos-
phate dehydrogenase to discriminate between cervical intra-
epithelial neoplasias and normal tissue. In tackling this
objective we have used our recently developed method (Slater
et al., 1992) for isolating purified suspensions of epithelial
cells obtained from uterine cervix by normal sampling proce-
dures. A secondary objective was to confirm that any in-
creased pentose shunt activity, as measured biochemically
with glucose-6-phosphate dehydrogenase (G6PD), was an188 S.K. JONAS et al.
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Figure 2 Frequency distribution histograms of staining intensity from a normal and a pre-cancerous smear. Following Percoll
gradient separation cells were stained for 6PGD as described in the text. Staining was measured by computerised microcytospectro-
photometry at 540 nm. N = number of cells measured.
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* * * A stimulus for this study was the report (Rees et al., 1970)
more than 20 years ago, concerning G6PD activity in sam-
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tribute to measurements of total G6PD activity. The present
results, which are much better than reported earlier by Rees
et al. encourage us to proceed along this path to develop a
simple and reliable biochemical screening test for CIN and
NOR (n = 61) cervical carcinoma.
G6PD is known to be increased in tumour cells generally
(Weber, 1977) and in other dividing cells. Heyden (1974) has
shown by histochemical techniques that G6PD is increased in
lesions of the human uterine cervix. The enzyme is important
not only for participating in the supply of pentose sugars for
nucleic acid synthesis but also for producing NADPH and
thus changing the redox couple NADP+/NADPH. In this
30 40 50 60 respect it is known that an increased emphasis in the reduc-
O.D. 0.15 units at 540 nm ing status of a cell can influence the up-regulation of throm-
boxane receptors on the cell surface. Thromboxane has been
th staining intensity above extinc- shown in a number of tumour systems to be a stimulator of
Cells were stained for 6PGD as cell division (Nigam & Averdunk, 1989). It is germane to
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Le figure shows the percentage of pre-malignant and malignant disorders of the uterine cervix
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Figure 4 G6PD activity in lysed cervix cells from normal patients and patients with CIN. The activity of G6PD, measured
biochemically, in lysed samples of cervix epithelial cells were obtained and processed as described in the text. The figure shows the
distribution of activity found in cells obtained from normal women, and from women with CIN-1, 2 or 3. Each point represents a
different patient. An arbitrary discriminatory dashed line was drawn to produce the values for false negatives and positives given in
the text.
Table I False negatives and false positives in normal samples and
samples from CIN
Normal CIN I CIN 2 CIN 3 All CIN
false false false false false
positives negatives negatives negatives negatives
Cytochemistry 4 (61) 6 (14) 1 (11) 6 (15) 13 (40)
6.6% 43% 9% 40% 33%
Biochemistry 3 (21) 1 (9) 0 (10) 0 (14) 1 (33)
14% 11% 0% 0% 3%
The data show the number of samples from normal women, and
women with CIN 1, 2 or 3, that stained for 6PGD above or below the
discriminatory line drawn in Figure 3 (cytochemistry). Similarly, the
number of samples with activities of G6PD above or below the
discriminatory linedrawn inFigure4isshown(biochemistry). Numbers
in parenthesis = total number of cells.
Biochemical measurements
As shown in Figure 4 there are significant differences in
G6PD activity in lysed cell preparations obtained from sam-
ples identified as CIN 1, 2 or 3 compared with samples taken
from normal females. With a discriminatory line drawn as
indicated (equivalent to an activity of 17 O.D. units x 10-
per minute per 104 cells) there are no false negatives for
samples of CIN 2 and 3 and approximately 10% for CIN 1.
The false positive value for the normal group was approx-
imately 14%.
The three 'unusually' high values for normals in Figure 4
could be due to (a) misdiagnosis, although all cases shown in
Figure 4 had been examined cytologically; (b) as yet ill-
defined influences such as concurrent hormone replacement
therapy at the time of sampling, heavy smoking etc.
The one 'unusual' value for CIN 1 could again be due to
misdiagnosis, or to failures in sampling and storage prior to
collection for analysis.
The distribution of G6PD values in the normal group
suggests that enzyme activity is not significantly affected by
the stage of the menstrual cycle as the cases studied were
randomly distributed through the cycle.
In contrast to the values for the normal group the values
for CIN 1, 2 and 3 were widely distributed (Figure 4). This
suggests that there may be different degrees of pre-malig-
nancy within each of the conventional stages as suggested
recently by Pinion et al. (1991). It is important to emphasise
that the biochemical method, unlike the microcytospectro-
photometry, uses only simple, inexpensive equipment and
that it is easily adaptable for automation and routine use.
The use of measurements of G6PD activity in suspensions of
cervical cells for diagnosis of CIN has been the subject of a
provisional patent (no. 203633.4).
Microcytospectrophotometric measurements
The quantitative microcytospectrophotometry was used here
to supplement the biochemical assays. It is clear that quan-
titative microcytospectrophotometry is entirely unsuited to
routine use but in this study it has confirmed that the large
differences found by biochemical assay of the pentose path-
way (Figure 4) can be visualised and measured in individual
cervical cells by microcytospectrophotometry (Figure 1). This
was important to show in order to eliminate the possibility
that the biochemical study was measuring G6PD in cells
other than those of epithelial cells of the cervix. It should be
noted that the microcytospectrophotometry entailed measur-
ing formazan production in at least 100 cells per patient
sample; the cytochemical results in Table I thus represent
more than 10,000 individual measurements. The Table sup-
ports the differences found by biochemical measurements of
pentose shunt activity between normal and cases of CIN. The
false positives for normals in this case were comparable in
both methods used. However, the false negatives for all the
CIN groups were considerably worse for the cytochemistry
than for the biochemistry. This suggests that the biochemical
method used here is considerably more reliable. It measured
at least 103 times as many cells and is thus more sensitive in
detecting small increases in enzyme activity. Overlap between
grades would be expected, due to the uncertainty of direct
correlation between the clinical classification of CIN as diag-
nosed by standard histology and biochemical changes as
detected by our method. Many of the abnormalities observed
in a PAP smear or by histology may not reflect the degree of
biochemical changes occurring. For instance, the increased
biochemical activity is not necessarily accompanied by
enlarged nuclei (see Figure 1), indicating that these changes
may be taking place long before any obvious morphological
alteration. There may be therefore a genuine overlap between
normal and CIN in terms of biochemistry. It is conceivable
that some cases of CIN may be reverting back to normal and
some normal cases may be in the process of transition to
CIN. The spontaneous reversibility of CIN to normality has
been shown previously in histopathology studies (Anderson,
1985; McIndoe et al., 1984). This may explain some of the
high values obtained for normal samples. It seems plausible
to consider samples with G6PD activity greater than 17 O.D.190 S.K. JONAS et al.
units x 10-5 per minute per 104 cells as suspicious and war-
ranting further investigation.
The cytochemical studies reported here confirm the con-
clusions reached above concerning the biochemical measure-
ments: there is an increased 6PGD activity in cervix epithelial
cells in CIN compared with normal. The values in CIN are
widely dispersed (Figure 3), again suggesting that different
degrees of biochemical aberration occur within these three
morphologically defined sub-groups.
Our previous work on protein thiols in CIN and cervix
carcinoma (Slater et al., 1985; Nohammer et al., 1989;
Benedetto et al., 1990) has demonstrated the occurrence of a
biochemical field effect in which biochemical changes occur
in morphologically normal cells some distance from the
morphologically identifiable lesion. An important recent
finding (McDermott et al., 1990) has found changes in G6PD
in apparently normal areas of the breast distant from the site
of a carcinoma. It will be of obvious importance to inves-
tigate whether a similar G6PD field effect occurs in CIN and
cervix carcinoma; this is under active investigation.
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